Netarsudil, latanoprost fixed-dose combo outperforms monotherapies in IOP control

• Posted on: Nov 26 2019
• By: Saratoga Opthalmology
• Leave a response

This study compared the efficacy of a fixed-dose netarsudil/latanoprost combination therapy versus individual monotherapies for open-angle glaucoma and ocular hypertension.
Source: AAO

Posted in: Uncategorized